- Category
- Micro (2024-25)
- Udyam number
- UDYAM-HR-13-0000171

About Deltis Pharma Private Limited
Data last updated:
Deltis Pharma Private Limited is a private limited company based in Naraingarh, Haryana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 02 July 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24304HR2020PTC087164. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹15 Lakh. It is led by directors Sher Singh and Vashist Sandhu.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C/O Sushil Kashyap Mauja Dera, Naraingarh, Haryana, India – 134203.
As per the financials filed for FY 2023, the company reported a revenue of ₹1.37 Cr, a decline of 34% compared to the previous year. For the same year it recorded a net loss of ₹15.01 Lakh (net margin -11%) and EBITDA of ₹44.04 Lakh (EBITDA margin 32.2%).
Deltis Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-13-0000171). For more details, the company can be reached via its website deltispharma.com.
Company details
Recognitions & Rankings of Deltis Pharma
Contact details
Deltis Pharma Private Limited's registered office is in Naraingarh, Haryana. Its website is deltispharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressC/O Sushil Kashyap Mauja Dera, Naraingarh, Haryana, India – 134203
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Deltis Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Deltis Pharma Private Limited
FY 2025 filings availableDeltis Pharma Private Limited reported revenue of ₹1.37 Cr (down 34% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue fell 34% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | ₹1.37 Cr | ||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹44.04 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹15.01 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 32.2% | ||
| Net Profit Margin | -11% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Deltis Pharma Private Limited, buy the company report.
Board of directors of Deltis Pharma Private Limited
Deltis Pharma has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sher Singh | Director | 20 Apr 2022 | 4 Years 6 Months | Current |
| Vashist Sandhu | Director | 05 Feb 2021 | 5 Years 8 Months | Current |
Auditor
Deltis Pharma Private Limited is audited by SHIVA MITTAL for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SHIVA MITTAL | FY 2023 | 532896 |
Shareholding
The shareholding of Deltis Pharma Private Limited is on record for 3 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Deltis Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Deltis Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Deltis Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Deltis Pharma Private Limited has 1 active EPFO establishment as of Apr 11, 2024.
GST
Deltis Pharma has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Deltis Pharma Private Limited, buy the company report.
Recent activity
Deltis Pharma Private Limited has 6 board changes on record since 2021: 2 appointments and 4 cessations. The latest: Jitender Singh ceased to be Director on 30 Mar 2024.
Frequently asked questions
Deltis Pharma is an active private limited company based in Naraingarh, Haryana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 02 July 2020 (6+ years old) and is registered under CIN U24304HR2020PTC087164.
Deltis Pharma has 2 current directors:
- Sher Singh - Director
- Vashist Sandhu - Director
The latest financial statements of Deltis Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
No. Deltis Pharma has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Deltis Pharma is U24304HR2020PTC087164. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Deltis Pharma was incorporated on 02 July 2020, making it 6+ years old. It is registered with the Registrar of Companies, Delhi.
Jitender Singh ceased to be Director on 30 Mar 2024. Sher Singh ceased to be Additional Director on 30 Sep 2022. Sher Singh was appointed as Director on 20 Apr 2022. Deltis Pharma has 6 board changes on record in total.
Yes, Deltis Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-HR-13-0000171).
Deltis Pharma can be reached through the website deltispharma.com. Its registered office is in Naraingarh, Haryana, India.
The registered office of Deltis Pharma is at CO Sushil Kashyap Mauja Dera, Naraingarh, Haryana, India – 134203.

